Acadian Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,827
| Closed | -$94K | – | 1900 |
|
|
2022
Q2 | $94K | Buy |
+31,827
| New | +$94K | ﹤0.01% | 1370 |
|
|
2020
Q2 | – | Sell |
-611,297
| Closed | -$906K | – | 2371 |
|
|
2020
Q1 | $906K | Buy |
611,297
+198,002
| +48% | +$293K | 0.01% | 825 |
|
|
2019
Q4 | $810K | Buy |
+413,295
| New | +$810K | ﹤0.01% | 936 |
|
|
2018
Q2 | – | Sell |
-33,802
| Closed | -$439K | – | 1884 |
|
|
2018
Q1 | $439K | Buy |
+33,802
| New | +$439K | ﹤0.01% | 891 |
|
|
2017
Q2 | – | Sell |
-29,969
| Closed | -$129K | – | 1630 |
|
|
2017
Q1 | $129K | Buy |
+29,969
| New | +$129K | ﹤0.01% | 1101 |
|
|
2015
Q2 | – | Sell |
-30,383
| Closed | -$211K | – | 1528 |
|
|
2015
Q1 | $211K | Buy |
+30,383
| New | +$211K | ﹤0.01% | 914 |
|